In the USA Another Covid-19 vaccine is about to be approved. A panel of experts from the FDA approved the emergency approval of the vaccine on Friday Johnson & Johnson. The vote is not binding. As a rule, however, the FDA follows the recommendations of this commission within a very short time.
In the USA so far the Covid-19 vaccines approved by Biontech / Pfizer and Moderna. For the European Union, the drug authority EMA wants to decide on conditional marketing authorization for the vaccine from Johnson & Johnson by mid-March. Bahrain was the first country in the world to issue emergency approval to the agent on Thursday.
Compared to the other vaccines that have already been approved, the one from Johnson & Johnson has the advantage that a single dose should be sufficient instead of two doses. In addition, the preparation does not have to be stored frozen, which makes it easier to distribute.
Johnson & Johnson had in late January for the agent an effectiveness of 66 percent reported on protection against moderate to severe Covid-19 courses in its global study with around 44,000 participants. In preventing hospitalization, the vaccine was 85 percent effective 14 days after vaccination and 100 percent effective 28 days.